Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Completion of phase I study of vaccinia immune globulin

Aug. 5, 2003

Stimulation of the dopamine D4 receptor enhances novelty-seeking behavior in mice

July 25, 2003

Improved iron balance found for deferasirox in iron-loaded patients with beta-thalassemia

July 9, 2003

Pilot study of Probuphine initiated for treatment of opiate addiction

June 30, 2003

Pharmacokinetic data support use of oral deferasirox in transfusional hemosiderosis

June 27, 2003

Pfizer researchers describe new neuronal nAChR ligands for nicotine addiction

June 23, 2003

Second phase IIa study for TA-CD in cocaine dependence reports findings

June 19, 2003

Agents for iron overload therapy disclosed by Novartis researchers

June 3, 2003

Nippon Shinyaku acquires Japanese rights to acamprosate

May 28, 2003

Rat study suggests potential of topiramate in treating nicotine addiction

May 8, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...